Cite

HARVARD Citation

    Mustafa, N. et al. (2021). Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma. Journal for immunotherapy of cancer. 9 (7), p. . [Online]. 
  
Back to record